PCOR insider files Form 144 to sell 4,205 restricted shares on NYSE
Rhea-AI Filing Summary
Form 144 filed for Procore Technologies, Inc. (PCOR) reports a proposed sale of 4,205 common shares through Morgan Stanley Smith Barney with an aggregate market value of $267,715.95, expected to occur on 08/21/2025 on the NYSE. The shares were acquired as restricted stock from the issuer on 08/20/2025 and payment was recorded on the same date. The filing also discloses multiple recent sales by the same person, Benjamin C. Singer, between 07/10/2025 and 07/21/2025, totaling several transactions in common stock with gross proceeds shown for each trade.
Positive
- Clear compliance with Rule 144 reporting, specifying broker, share count, value, and sale date
- Use of a major broker (Morgan Stanley Smith Barney) and NYSE listing, indicating standard execution and transparency
Negative
- No information provided about whether a Rule 10b5-1 plan governs the sale (plan adoption date not stated)
- Insider sold multiple shares in July, which could indicate ongoing disposition though amounts are modest
Insights
TL;DR: Insider intends to sell newly acquired restricted shares worth ~$268k via a broker on 08/21/2025; prior small sales occurred in July.
The filing documents a routine Rule 144 notice for the sale of 4,205 restricted common shares received from the issuer one day earlier. Using Morgan Stanley Smith Barney as broker and listing NYSE as the venue are standard for compliance and liquidity. The nearby July sales by the same individual indicate prior disposition activity but are modest in size relative to many public-company free floats. This notice provides required transparency under Rule 144 but does not include any additional material disclosures about the issuers operations or financial condition.
TL;DR: The Form 144 appears compliant and procedural; no governance or regulatory red flags are evident from the filing content alone.
The document shows the sellers representation about lack of undisclosed material information and cites potential Rule 10b5-1 plan considerations, though no plan adoption date is provided. The acquisition as restricted stock on 08/20/2025 followed by a Form 144 notice suggests timing consistent with planned disposition under applicable resale rules. Without additional context on insider role, holdings concentration, or company events, the filing itself reads as a routine disclosure rather than a governance concern.